The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Rachmani, R., Slavachevsky, I., Amit, M., Levi, Z., Kedar, Y., Berla, M., & Ravid, M. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01194.x · Cited by 142
RetractedReduction of Microalbuminuria in Patients With Type 2 Diabetes
The Shiga Microalbuminuria Reduction Trial (SMART) Group (2007) · Diabetes Care · doi:10.2337/dc06-2493 · Cited by 62
RetractedLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
General methods for monitoring convergence of iterative simulations
Brooks, S. P., & Gelman, A. (1998) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1998.10474787 · Cited by 6,045
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Salanti, G., Ades, A. E., & Ioannidis, J. P. A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.016 · Cited by 3,766
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Checking consistency in mixed treatment comparison meta-analysis
Dias, S., Welton, N. J., Caldwell, D. M., & Ades, A. E. (2010) · Statistics in Medicine · doi:10.1002/sim.3767 · Cited by 2,521
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452
Mann, J. F. E., Gerstein, H. C., Pogue, J., Bosch, J., Yusuf, S., & for the HOPE Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00007 · Cited by 1,372
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208799 · Cited by 1,319
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Parving, H.-H., Persson, F., Lewis, J. B., Lewis, E. J., & Hollenberg, N. K. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708379 · Cited by 1,098
Herzog, C. A., Asinger, R. W., Berger, A. K., Charytan, D. M., Díez, J., Hart, R. G., Eckardt, K.-U., Kasiske, B. L., McCullough, P. A., Passman, R. S., et al. (2011) · Kidney International · doi:10.1038/ki.2011.223 · Cited by 922
Ruggenenti, P., Perna, A., Gherardi, G., Garini, G., Zoccali, C., Salvadori, M., Scolari, F., Schena, F. P., & Remuzzi, G. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10363-x · Cited by 910
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
Barnett, A. H., Bain, S. C., Bouter, P., Karlberg, B., Madsbad, S., Jervell, J., & Mustonen, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042274 · Cited by 910
Viberti, G., & Wheeldon, N. M. (2002) · Circulation · doi:10.1161/01.cir.0000024416.33113.0a · Cited by 802
Ravid, M., Savin, H., Jutrin, I., Bental, T., Katz, B., & Lishner, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-8-199304150-00001 · Cited by 775
Tonelli, M., Muntner, P., Lloyd, A., Manns, B. J., Klarenbach, S., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60572-8 · Cited by 718
Efficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency
Hou, F. F., Zhang, X., Zhang, G. H., Xie, D., Chen, P. Y., Zhang, W. R., Jiang, J. P., Liang, M., Wang, G. B., Liu, Z. R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053107 · Cited by 710
Early recognition and prevention of chronic kidney disease
James, M. T., Hemmelgarn, B. R., & Tonelli, M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62004-3 · Cited by 606
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
Schrier, R. W., Abebe, K. Z., Perrone, R. D., Torres, V. E., Braun, W. E., Steinman, T. I., Winklhofer, F. T., Brosnahan, G., Czarnecki, P. G., Hogan, M. C., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402685 · Cited by 528
Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria
Asselbergs, F. W., Diercks, G. F. H., Hillege, H. L., van Boven, A. J., Janssen, W. M. T., Voors, A. A., de Zeeuw, D., de Jong, P. E., van Veldhuisen, D. J., & van Gilst, W. H. (2004) · Circulation · doi:10.1161/01.cir.0000146378.65439.7a · Cited by 523
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.46 · Cited by 521
van Vark, L. C., Bertrand, M., Akkerhuis, K. M., Brugts, J. J., Fox, K., Mourad, J.-J., & Boersma, E. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs075 · Cited by 460
Renal protective effect of enalapril in diabetic nephropathy.
Bjorck, S., Mulec, H., Johnsen, S. A., Norden, G., & Aurell, M. (1992) · BMJ · doi:10.1136/bmj.304.6823.339 · Cited by 432
Heerspink, H. J. L., Ninomiya, T., Zoungas, S., de Zeeuw, D., Grobbee, D. E., Jardine, M. J., Gallagher, M., Roberts, M. A., Cass, A., Neal, B., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60212-9 · Cited by 430
Self-citationBakris, G. L., Copley, J. B., Vicknair, N., Sadler, R., & Leurgans, S. (1996) · Kidney International · doi:10.1038/ki.1996.480 · Cited by 417
Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system
(2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280bad9b4 · Cited by 414
Berl, T., Hunsicker, L. G., Lewis, J. B., Pfeffer, M. A., Porush, J. G., Rouleau, J.-L., Drury, P. L., Esmatjes, E., Hricik, D., Parikh, C. R., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-7-200304010-00010 · Cited by 402
Mehdi, U. F., Adams-Huet, B., Raskin, P., Vega, G. L., & Toto, R. D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070737 · Cited by 388
Viberti, G. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510280037029 · Cited by 381
Treatment of IgA Nephropathy with ACE Inhibitors: A Randomized and Controlled Trial
Praga, M., Gutiérrez, E., González, E., Morales, E., & Hernández, E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068460.37369.dc · Cited by 345
Zannad, F., Kessler, M., Lehert, P., Grünfeld, J. P., Thuilliez, C., Leizorovicz, A., Lechat, P., & for the Fosidial Investigators (2006) · Kidney International · doi:10.1038/sj.ki.5001657 · Cited by 332
Marre, M., Lievre, M., Chatellier, G., Mann, J. F. E., Passa, P., & Ménard, J. (2004) · BMJ · doi:10.1136/bmj.37970.629537.0d · Cited by 296
Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease
Torres, V. E., Abebe, K. Z., Chapman, A. B., Schrier, R. W., Braun, W. E., Steinman, T. I., Winklhofer, F. T., Brosnahan, G., Czarnecki, P. G., Hogan, M. C., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402686 · Cited by 291
Li, P. K.-T., Chow, K.-M., Wong, T. Y.-H., Leung, C.-B., & Szeto, C.-C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00010 · Cited by 289
Laffel, L. M. B., McGill, J. B., & Gans, D. J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80226-5 · Cited by 279
Long-term comparison between captopril and nifedipine in the progression of renal insufficiency
Zucchelli, P., Zuccalà, A., Borghi, M., Fusaroli, M., Sasdelli, M., Stallone, C., Sanna, G., & Gaggi, R. (1992) · Kidney International · doi:10.1038/ki.1992.309 · Cited by 270
Blood Pressure Lowering Treatment Trialists' Collaboration (2013) · BMJ · doi:10.1136/bmj.f5680 · Cited by 263
Hou, F. F., Xie, D., Zhang, X., Chen, P. Y., Zhang, W. R., Liang, M., Guo, Z. J., & Jiang, J. P. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121372 · Cited by 251
for the ORIENT study investigators, Imai, E., Chan, J. C. N., Ito, S., Yamasaki, T., Kobayashi, F., Haneda, M., & Makino, H. (2011) · Diabetologia · doi:10.1007/s00125-011-2325-z · Cited by 236
Wu, H.-Y., Huang, J.-W., Lin, H.-J., Liao, W.-C., Peng, Y.-S., Hung, K.-Y., Wu, K.-D., Tu, Y.-K., & Chien, K.-L. (2013) · BMJ · doi:10.1136/bmj.f6008 · Cited by 233
Agarwal, R., Sinha, A. D., Pappas, M. K., Abraham, T. N., & Tegegne, G. G. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft515 · Cited by 232
Lacourcière, Y., Bélanger, A., Godin, C., Hallé, J.-P., Ross, S., Wright, N., & Marion, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00224.x · Cited by 229
Rahman, M., Pressel, S., Davis, B. R., Nwachuku, C., Wright, J. T., Whelton, P. K., Barzilay, J., Batuman, V., Eckfeldt, J. H., Farber, M. A., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-3-200602070-00005 · Cited by 227
Li, P. K.-T., Leung, C. B., Chow, K. M., Cheng, Y. L., Fung, S. K.-S., Mak, S. K., Tang, A. W.-C., Wong, T. Y.-H., Yung, C. Y., Yung, J. C.-U., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.01.017 · Cited by 223
Randomised controlled trial of enalapril and β blockers in non- diabetic chronic renal failure
Hannedouche, T., Landais, P., Goldfarb, B., Esper, N. E., Fournier, A., Godin, M., Durand, D., Chanard, J., Mignon, F., Suc, J.-M., et al. (1994) · BMJ · doi:10.1136/bmj.309.6958.833 · Cited by 220
Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria
The Microalbuminuria Captopril Study Group (1996) · Diabetologia · doi:10.1007/bf00403306 · Cited by 208
Takahashi, A., Takase, H., Toriyama, T., Sugiura, T., Kurita, Y., Ueda, R., & Dohi, Y. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl293 · Cited by 206
Song, F., Xiong, T., Parekh-Bhurke, S., Loke, Y. K., Sutton, A. J., Eastwood, A. J., Holland, R., Chen, Y.-F., Glenny, A.-M., Deeks, J. J., et al. (2011) · BMJ · doi:10.1136/bmj.d4909 · Cited by 199
Ahmad, J., Siddiqui, M. A., & Ahmad, H. (1997) · Diabetes Care · doi:10.2337/diacare.20.10.1576 · Cited by 198
Suzuki, H., Kanno, Y., Sugahara, S., Ikeda, N., Shoda, J., Takenaka, T., Inoue, T., & Araki, R. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.04.031 · Cited by 191
Solomon, S. D., Rice, M. M., A. Jablonski, K., Jose, P., Domanski, M., Sabatine, M., Gersh, B. J., Rouleau, J., Pfeffer, M. A., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.105.592733 · Cited by 190
Nielsen, F. S., Rossing, P., Gall, M.-A., Skøtt, P., Smidt, U. M., & Parving, H.-H. (1997) · Diabetes · doi:10.2337/diab.46.7.1182 · Cited by 183
Tokmakova, M. P., Skali, H., Kenchaiah, S., Braunwald, E., Rouleau, J. L., Packer, M., Chertow, G. M., Moyé, L. A., Pfeffer, M. A., & Solomon, S. D. (2004) · Circulation · doi:10.1161/01.cir.0000149806.01354.bf · Cited by 183
Nielsen, F. S., Rossing, P., Gall, M. A., Skott, P., Smidt, U. M., & Parving, H. H. (1997) · Diabetes · doi:10.2337/diabetes.46.7.1182 · Cited by 182
Cice, G., Di Benedetto, A., D'Isa, S., D'Andrea, A., Marcelli, D., Gatti, E., & Calabrò, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.105 · Cited by 170
Effect of Enalapril on the Progression of Chronic Renal Failure
Kamper, A.-L., Strandgaard, S., & Leyssac, P. P. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.7.423 · Cited by 163
Norris, K. C., Bourgoigne, J., Gassman, J., Hebert, L. A., Middleton, J. P., Phillips, R. A., Randall, O. S., Rostand, S. G., Sherer, S., Toto, R. D., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.08.004 · Cited by 163
Marre, M., Puig, J. G., Kokot, F., Fernández, M., Jermendy, G., Opie, L. H., Moyseev, V., Scheen, A. J., Ionescu-Tirgoviste, C., Saldanha, M. H., et al. (2004) · Journal of Hypertension · doi:10.1097/01.hjh.0000133733.32125.09 · Cited by 159
Tobe, S. W., Clase, C. M., Gao, P., McQueen, M., Grosshennig, A., Wang, X., Teo, K. K., Yusuf, S., & Mann, J. F. E. (2011) · Circulation · doi:10.1161/circulationaha.110.964171 · Cited by 152
AGARDH, C. ‐., García‐Puig, J., Charbonnel, B. H., Angelkort, B., & Barnett, A. H. (1996) · PubMed · Cited by 139
Ihle, B. U., Whitworth, J. A., Shahinfar, S., Cnaan, A., Kincaid‐Smith, P., & Becker, G. J. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90158-4 · Cited by 129
Crepaldi, G., Carta, Q., Deferrari, G., Mangili, R., Navalesi, R., Santeusanio, F., Spalluto, A., Vanasia, A., Villa, G., Nosadini, R., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.104 · Cited by 124
O'Hare, P. J., Bilbous, R., Mitchell, T., Callaghan, C. J. O., Viberti, G. C., & Ace-Inhibitor Trial to Lower Albuminuria in Normotensive Insulin-Dependent Subjects Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1823 · Cited by 120
A Randomized Trial of Captopril for Microalbuminuria in Normotensive Adults with Sickle Cell Anemia
Foucan, L., Bourhis, V. M., Bangou, J., Mérault, L., Etienne‐Julan, M., & Salmi, L. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00056-4 · Cited by 120
Perkovic, V., Ninomiya, T., Arima, H., Gallagher, M., Jardine, M., Cass, A., Neal, B. C., MacMahon, S. W., & Chalmers, J. P. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020256 · Cited by 106
Self-citationHeerspink, H. J. L., Ninomiya, T., Perkovic, V., Woodward, M., Zoungas, S., Cass, A., Cooper, M. E., Grobbee, D. E., Mancia, G., Mogensen, C. E., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq139 · Cited by 104
Self-citationIseki, K., Arima, H., Kohagura, K., Komiya, I., Ueda, S., Tokuyama, K., Shiohira, Y., Uehara, H., Toma, S., Tomiyama, N., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs590 · Cited by 104
Fogari, R., Zoppi, A., Corradi, L., Mugellini, A., Lazzari, P., Preti, P., & Lusardi, P. (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000732 · Cited by 96
Tarnow, L., Rossing, P. R., Jensen, C., Hansen, B. V., & Parving, H. ‐. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1725 · Cited by 93
A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease
Marín, R., Ruilope, L. M., Aljama, P., Aranda, P. J., Segura, J., & Dı́ez, J. (2001) · Journal of Hypertension · doi:10.1097/00004872-200110000-00023 · Cited by 92
Muirhead, N., Feagan, B. F., Mahon, J. L., Lewanczuk, R. Z., Rodger, N. W., Botteri, F. M., Oddou-Stock, P., Pecher, E., & Cheung, R. M. C. (1999) · Current Therapeutic Research · doi:10.1016/s0011-393x(99)90003-6 · Cited by 88
No effect of enalapril on progression in autosomal dominant polycystic kidney disease
van Dijk, M. A., Breuning, M. H., Duiser, R., van Es, L. A., & Westendorp, R. G. J. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg417 · Cited by 86
Bowling, C. B., Sanders, P. W., Allman, R. M., Rogers, W. J., Patel, K., Aban, I. B., Rich, M. W., Pitt, B., White, M., Bakris, G. C., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.12.056 · Cited by 85
Juarez, G. M. F., Luño, J., Barrio, V., de Vinuesa, S. G., Praga, M., Goicoechea, M., Cachofeiro, V., Nieto, J., Vega, F. F., Tato, A., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.011 · Cited by 84
Trevisan, R., & Tiengo, A. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00162-i · Cited by 83
Vestra, M. D., Pozza, G., Mosca, A., Grazioli, V., Lapolla, A., Fioretto, P., & Crepaldi, G. (2004) · PubMed · Cited by 81
Makino, H., Haneda, M., Babazono, T., Moriya, T., Ito, S., Iwamoto, Y., Kawamori, R., Takeuchi, M., & Katayama, S. (2008) · Hypertension Research · doi:10.1291/hypres.31.657 · Cited by 79
Sano, T., Hotta, N., Kawamura, T., Matsumae, H., Chaya, S., Sasaki, H., Nakayama, M., Hara, T., Matsuo, S., & Sakamoto, N. (1996) · Diabetic Medicine · Cited by 78
Nutahara, K., Higashihara, E., Horie, S., Kamura, K., Tsuchiya, K., Mochizuki, T., Hosoya, T., Nakayama, T., Yamamoto, N., Higaki, Y., et al. (2005) · Nephron Clinical Practice · doi:10.1159/000081790 · Cited by 77
Bauer, J. H., Reams, G. P., Hewett, J. E., Klachko, D. M., Lau, A., Messina, C. R., & Knaus, V. L. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70256-1 · Cited by 69
Herlitz, H., Harris, K. M., Risler, T., Boner, G., Bernheim, J., Chanard, J., & Aurell, M. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.11.2158 · Cited by 63
Katayama, S., Kikkawa, R., ISOGAI, S., Sasaki, N., Matsuura, N., Tajima, N., Urakami, T., Uchigata, Y., & Ohashi, Y. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00289-3 · Cited by 59
Fogari, R., Mugellini, A., Zoppi, A., Lazzari, P., Destro, M., Rinaldi, A., & Preti, P. S. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0961-2 · Cited by 57
Nankervis, A. J., Nicholls, K., Kilmartin, G., Allen, P., Ratnaike, S., & Martin, F. I. R. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90364-x · Cited by 56
Kanno, Y., Takenaka, T., Nakamura, T., & Suzuki, H. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01110905 · Cited by 56
Saruta, T., Hayashi, K., Ogihara, T., Nakao, K., Fukui, T., Fukiyama, K., & for the CASE-J Study Group (2009) · Hypertension Research · doi:10.1038/hr.2009.44 · Cited by 55
Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy
Elving, L. D., Wetzels, J. F. M., van Lier, H. J. J., de Nobel, E., & Berden, J. H. M. (1994) · Diabetologia · doi:10.1007/bf00403380 · Cited by 54
Zeltner, R., Poliak, R., Stiasny, B., Schmieder, R. E., & Schulze, B. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm731 · Cited by 54
Brugts, J. J., Boersma, E. H., Chonchol, M., Deckers, J. W., Bertrand, M. E., Remme, W. J., Ferrari, R., Fox, K. M., & Simoons, M. L. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.029 · Cited by 53
Steinman, T. I. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm865 · Cited by 52
Ogawa, S., Takeuchi, K., Mori, T., Nako, K., Tsubono, Y., & Ito, S. (2007) · Hypertension Research · doi:10.1291/hypres.30.325 · Cited by 51
Cinotti, G. A., & Zucchelli, P. C. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.5.961 · Cited by 50
van Essen, G. G., Apperloo, A. J., Rensma, P. L., Stegeman, C. A., Sluiter, W. J., de Zeeuw, D., & de Jong, P. E. (1997) · PubMed · Cited by 49
The PROCOPA Study Group (2002) · Journal of Hypertension · doi:10.1097/00004872-200204000-00032 · Cited by 48
Suzuki, H., Kanno, Y., Kaneko, K., Kaneko, M., Kotaki, S., Mimura, T., & Takane, H. (2004) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1526-0968.2004.00142.x · Cited by 43
Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.
O'Donnell, M. J., Rowe, B. R., Lawson, N., Horton, A., Gyde, O. H., & Barnett, A. H. (1993) · PubMed · Cited by 40
Bojestig, M., Karlberg, B. E., Lindström, T., & Nyström, F. H. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.919 · Cited by 40
Esnault, V. L. M., BROWN, E., Apetrei, E., Bagon, J. A., Calvo, C., deChâtel, R., Holdaas, H., Krcmery, S., & Kobalava, Z. D. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.03.006 · Cited by 39
Schnack, C., Hoffmann, W. E., Hopmeier, P., & Schernthaner, G. (1996) · Diabetologia · doi:10.1007/s001250050623 · Cited by 36
Effect of Ramipril on Left Ventricular Mass in Normotensive Hemodialysis Patients
Yu, W., Lin, Y., Lin, I., Chuang, S., & Chen, C.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.11.024 · Cited by 36
Kjærgaard, K. D., Peters, C. D., Jespersen, B., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.011 · Cited by 35
Beneficial effects of high-dose losartan in IgA nephritis
Woo, K. T., Chan, C.-M., Tan, H. K., Choong, H. L., Foo, M. W. Y., Vathsala, A., Lee, E. J. C., Tan, C., Lee, G. S. L., Tan, S. H., et al. (2009) · Clinical Nephrology · doi:10.5414/cnp71617 · Cited by 33
Kumagai, H., Hayashi, K., Kumamaru, H., & Saruta, T. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00287-9 · Cited by 33
Shoda, J., Kanno, Y., & Suzuki, H. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1515 · Cited by 32
Nakamura, T., Kanno, Y., Takenaka, T., & Suzuki, H. (2005) · Hypertension Research · doi:10.1291/hypres.28.415 · Cited by 31
Yılmaz, R., Altun, B., Kahraman, S., Ozer, N., Akıncı, D., & Turgan, Ç. (2010) · Renal Failure · doi:10.3109/0886022x.2010.502276 · Cited by 30
Krimholtz, M., Karalliedde, J. J., Thomas, S., Bilous, R., & Viberti, G. C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110973 · Cited by 28
for the Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group, Rakugi, H., Ogihara, T., Umemoto, S., Matsuzaki, M., Matsuoka, H., Shimada, K., Higaki, J., Ito, S., Kamiya, A., et al. (2013) · Hypertension Research · doi:10.1038/hr.2013.63 · Cited by 27
Treatment of Early Immunoglobulin A Nephropathy by Angiotensin-converting Enzyme Inhibitor
Li, P. K., Kwan, B. C., Chow, K., Leung, C., & Szeto, C. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.06.028 · Cited by 26
Usta, M., Ersoy, A., Dilek, K., et al. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01071.x · Cited by 26
Vascular compliance is secured under angiotensin inhibition in non-diabetic chronic kidney diseases
Mimura, T., Takenaka, T., Kanno, Y., Moriwaki, K., Okada, H., & Suzuki, H. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002264 · Cited by 25
Tong, P. C. Y., Ko, G. T. C., Chan, W. ‐., Ma, R. C. W., So, W. Y., Lo, M. K. W., Lee, K.-H., Ozaki, R., Chow, C. C., Cockram, C. S., et al. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00514.x · Cited by 24
for the KVT Study Group, Yasuda, T., Endoh, M., Suzuki, D., Yoshimura, A., Ideura, T., Tamura, K., Kamata, K., Toya, Y., Umemura, S., et al. (2012) · Hypertension Research · doi:10.1038/hr.2012.183 · Cited by 22
Capek, M., Schnack, C., Ludvik, B. H., Kautzky‐Willer, A., Banyai, M., & Prager, R. (1994) · Journal of Molecular Medicine · doi:10.1007/bf00577736 · Cited by 18
MACGREGOR, M. S., Deighan, C. J., Rodger, R. S. C., & Boulton‐Jones, J. M. (2005) · Nephron Clinical Practice · doi:10.1159/000086714 · Cited by 17
Zhang, G., Hou, F. F., Zhang, X., & Liu, Q.-F. (2005) · PubMed · Cited by 16
Petersen, L. J., Petersen, J. R., Talleruphuus, U., Møller, M., Ladefoged, S. D., Mehlsen, J., & Jensen, H. A. (2001) · PubMed · Cited by 15
Fuchs, F. D. (2012) · BMJ Evidence-Based Medicine · doi:10.1136/eb-2012-100851 · Cited by 14
Reyes-Marín, F. A., Calzada, C., Ballesteros, A., & Amato, D. (2012) · PubMed · Cited by 14
Deyneli, O., Yavuz, D. G., Velioğlu, A., et al. (2006) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2006.016 · Cited by 14
Shiga, T., Kasanuki, H., Hagiwara, N., Sumiyoshi, T., Honda, T., Haze, K., Takagi, A., Kawana, M., Origasa, H., Ogawa, H., et al. (2010) · Blood Pressure · doi:10.3109/08037051003802475 · Cited by 12
Fogari, R., Zoppi, A., Corradi, L., Poletti, L., Pasotti, M., Fogari, E., & Mugellini, A. (2000) · Current Therapeutic Research · doi:10.1016/s0011-393x(00)80014-4 · Cited by 9
Cited by
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Self-citationKDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452
Metadata
- Authors
- Xie, X., Liu, Y., Perkovic, V., Li, X., Ninomiya, T., Hou, W., Zhao, N., Liu, L., Lv, J., Zhang, H., & Wang, H.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 67
- Issue
- 5
- Pages
- 728-741
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2207247573
- Cited by
- 479
- References
- 135
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.